Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

An Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma.

Woodford D, Johnson SD, De Costa AM, Young MR.

J Clin Cell Immunol. 2014 Jun;5(3). pii: 230.

PMID:
25419481
[PubMed]
Free PMC Article
2.

Skewing of immune cell cytokine production by mediators from adipocytes and endothelial cells.

Vielma SA, Klein RL, Levingston CA, Young MR.

Adipocyte. 2014 Apr 1;3(2):126-31. doi: 10.4161/adip.28287. Epub 2014 Feb 25.

PMID:
24719786
[PubMed]
3.

Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer.

Johnson SD, De Costa AM, Young MR.

Cancers (Basel). 2014 Apr 2;6(2):756-70. doi: 10.3390/cancers6020756.

PMID:
24698959
[PubMed]
Free PMC Article
4.

Premalignant lesions skew spleen cell responses to immune modulation by adipocytes.

Vielma SA, Klein RL, Levingston CA, Young MR.

Anticancer Res. 2013 May;33(5):1809-18.

PMID:
23645725
[PubMed - indexed for MEDLINE]
5.

Adipocytes as immune regulatory cells.

Vielma SA, Klein RL, Levingston CA, Young MR.

Int Immunopharmacol. 2013 Jun;16(2):224-31. doi: 10.1016/j.intimp.2013.04.002. Epub 2013 Apr 13.

PMID:
23587489
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck.

Walker DD, Reeves TD, de Costa AM, Schuyler C, Young MR.

Cytokine. 2012 Jun;58(3):448-54. doi: 10.1016/j.cyto.2012.03.002. Epub 2012 Mar 24.

PMID:
22450225
[PubMed - indexed for MEDLINE]
Free PMC Article
7.
8.

Immunotherapy for head and neck cancer: advances and deficiencies.

De Costa AM, Young MR.

Anticancer Drugs. 2011 Aug;22(7):674-81. doi: 10.1097/CAD.0b013e328340fd18. Review.

PMID:
21037467
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma.

Walsh JE, Clark AM, Day TA, Gillespie MB, Young MR.

Hum Immunol. 2010 Jul;71(7):659-65. doi: 10.1016/j.humimm.2010.04.008. Epub 2010 May 16.

PMID:
20438786
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells.

Mailloux AW, Clark AM, Young MR.

Int J Cancer. 2010 Dec 1;127(11):2598-611. doi: 10.1002/ijc.25281.

PMID:
20198623
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2.

Mulligan JK, Rosenzweig SA, Young MR.

J Immunother. 2010 Feb-Mar;33(2):126-35. doi: 10.1097/CJI.0b013e3181b91c9c.

PMID:
20145550
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions.

Mulligan JK, Day TA, Gillespie MB, Rosenzweig SA, Young MR.

Hum Immunol. 2009 Jun;70(6):375-82. doi: 10.1016/j.humimm.2009.01.014. Epub 2009 Feb 12.

PMID:
19480853
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.

Mailloux AW, Young MR.

J Immunol. 2009 Mar 1;182(5):2753-65. doi: 10.4049/jimmunol.0801124.

PMID:
19234170
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells.

Kulbersh JS, Day TA, Gillespie MB, Young MR.

Otolaryngol Head Neck Surg. 2009 Feb;140(2):235-40. doi: 10.1016/j.otohns.2008.11.011.

PMID:
19201295
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Head and neck cancer disparities in South Carolina: descriptive epidemiology, early detection, and special programs.

Yen KL, Horner MJ, Reed SG, Daguise VG, Bolick-Aldrich SW, Young MR, Day TA, Wood PA, Hebert JR.

J S C Med Assoc. 2006 Aug;102(7):192-200. Review.

PMID:
17319230
[PubMed - indexed for MEDLINE]
16.

Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users.

Gillespie MB, Moody MW, Lee FS, Poole LJ, Hornig JD, Lathers D, Young MR, Day TA.

Arch Otolaryngol Head Neck Surg. 2007 Jan;133(1):28-31.

PMID:
17224518
[PubMed - indexed for MEDLINE]
17.

Combination docetaxel plus vitamin D(3) as an immune therapy in animals bearing squamous cell carcinomas.

Young MR, Lathers DM.

Otolaryngol Head Neck Surg. 2005 Oct;133(4):611-8.

PMID:
16213938
[PubMed - indexed for MEDLINE]
18.

Tumor skewing of CD34+ cell differentiation from a dendritic cell pathway into endothelial cells.

Young MR, Cigal M.

Cancer Immunol Immunother. 2006 May;55(5):558-68. Epub 2005 Jul 16.

PMID:
16025265
[PubMed - indexed for MEDLINE]
20.

Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck.

Lathers DM, Achille NJ, Young MR.

Hum Immunol. 2003 Dec;64(12):1160-6.

PMID:
14630398
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk